メニューにジャンプコンテンツにジャンプ

トップページ > 診療科・部門 > 診療科(外科系) > 泌尿器科 > 研究実績・活動実績 > 2016年度発表論文等一覧

2016年度発表論文等一覧

原著論文-英文

  1. Gong X, Siprashvili Z, Eminaga O, Shen Z, Sato Y, Kume H, Homma Y, Ogawa S, Khavari PA, Pollack JR, Brooks JD.
    Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.
    Oncotarget. 8(12):18657-18669, Mar 21, 2017.
  2. Nakagawa T, Komemushi Y, Kawai T, Otsuka M, Miyakawa J, Uemura Y, Kanatani A, Taguchi S, Naito A, Suzuki M, Nishimatsu H, Hirano Y, Tanaka Y, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.
    Efficacy of post-nephroureterectomy cisplatin-based adjuvant chemotherapy for locally advanced upper tract urothelial carcinoma: a multi-institutional retrospective study.
    World J Urol. 2017 in press.
  3. Yamada Y, Fujimura T, Fukuhara H, Sugihara T, Takemura K, Kakutani S, Suzuki M, Nakagawa T, Kume H, Igawa Y, Homma Y.
    Incidence and risk factors of inguinal hernia after robot-assisted radical prostatectomy.
    World J Surg Oncol. 15(1):61, Mar 16, 2017.
  4. Taguchi S, Buti S, Fukuhara H, Otsuka M, Bersanelli M, Morikawa T, Miyazaki H, Nakagawa T, Fujimura T, Kume H, Igawa Y, Homma Y.
    Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?
    PLoS One. 12(2):e0172341, Feb 27, 2017.
  5. Kamei J, Yagihara Y, Kume H, Horiuchi T, Sato T, Nakagawa T, Fujimura T, Fukuhara H, Moriya K, Homma Y.
    Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.
    Int J Urol. 24: 295-300, 2017.
  6. Aizawa N, Ito H, Sugiyama R, Fujimura T, Fukuhara H, Kume H, Homma Y, Igawa Y.
    Effects of Sildenafil, a Phosphodiesterase Type 5 Inhibitor, on the Primary Single Afferent Activity of the Rat Bladder.
    Low Urin Tract Symptoms. 9(1):57-61, Jan, 2017.
  7. Nakagawa T, Taguchi S, Uemura Y, Kanatani A, Ikeda M, Matsumoto A, Yoshida K, Kawai T, Nagata M, Yamada D, Komemushi Y, Suzuki M, Enomoto Y, Nishimatsu H, Ishikawa A, Nagase Y, Kondo Y, Tanaka Y, Okaneya T, Hirano Y, Shinohara M, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.
    Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladder.
    Urol Oncol. Jan 16, 2017. pii: S1078-1439(16)30418-5.
  8. Tsuda Y, Nakagawa T, Shinoda Y, Kanatani A, Kawai T, Taguchi S, Yamada Y, Sawada R, Kume H, Homma Y, Tanaka S, Kawano H.
    Skeletal-related events and prognosis in urothelial cancer patients with bone metastasis.
    Int J Clin Oncol. Jan 2, 2017.
  9. Yamada Y, Nakagawa T, Sugihara T, Horiuchi T, Yoshizaki U, Fujimura T, Fukuhara H, Urano T, Takayama K, Inoue S, Kume H, Homma Y.
    Prognostic value of CD66b positive tumor-infiltrating neutrophils in testicular germ cell tumor.
    BMC Cancer. 16(1):898, Nov 18, 2016.
  10. Nozaki K, Kamijo Y, Nakatsuka M, Azuma T, Nakagawa T, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Ishibashi Y, Homma Y.
    Computed tomography for the management of exit-site and tunnel infections in peritoneal dialysis patients.
    Clin Nephrol. 86 (2016)(12):328-332, Dec, 2016.
  11. Makino K, Nakagawa T, Kanatani A, Kawai T, Taguchi S, Otsuka M, Matsumoto A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Homma Y.
    Biphasic decline in renal function after radical cystectomy with urinary diversion.
    Int J Clin Oncol. 22(2):359-365, Apr, 2017. 
  12. Taguchi S, Fukuhara H, Morikawa T, Matsumoto A, Miyazaki H, Nakagawa T, Fujimura T, Kume H, Igawa Y, Homma Y.
    Cessation of long-term adjuvant androgen deprivation therapy after radical prostatectomy: is it feasible?
    Jpn J Clin Oncol. 46(12):1143-1147, Dec, 2016. Epub, Sep 12, 2016.
  13. Taguchi S, Shiraishi K, Fukuhara H, Nakagawa K, Morikawa T, Naito A, Kakutani S, Takeshima Y, Miyazaki H, Nakagawa T, Fujimura T, Kume H, Homma Y.
    Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial?
    Radiat Oncol. 11:102, Jul 30, 2016.
  14. Sonpavde G, Pond GR, Di Lorenzo G, Buonerba C, Rozzi A, Lanzetta G, Necchi A, Giannatempo P, Raggi D, Matsumoto K, Choueiri TK, Mullane S, Niegisch G, Albers P, Lee JL, Kitamura H, Kume H, Bellmunt J.
    Impact of Prior Platinum-Based Therapy on Patients Receiving Salvage Systemic Treatment for Advanced Urothelial Carcinoma.
    Clin Genitourin Cancer. 14(6):494-498, Dec, 2016.
  15. Naito A, Taguchi S, Nakagawa T, Matsumoto A, Nagase Y, Tabata M, Miyakawa J, Suzuki M, Nishimatsu H, Enomoto Y, Takahashi S, Okaneya T, Yamada D, Tachikawa T, Minowada S, Fujimura T, Fukuhara H, Kume H, Homma Y.
    Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladder.
    World J Urol. 35(1):97-103, Jan, 2017.
  16. Niimi A, Suzuki M, Yamaguchi Y, Ishii M, Fujimura T, Nakagawa T, Fukuhara H, Kume H, Igawa Y, Akishita M, Homma Y.
    Sleep Apnea and Circadian Extracellular Fluid Change as Independent Factors for Nocturnal Polyuria.
    J Urol. 196(4):1183-9, Oct, 2016.
  17. Taguchi S, Shiraishi K, Fukuhara H, Nakagawa K, Morikawa T, Naito A, Kakutani S, Takeshima Y, Miyazaki H, Nakagawa T, Fujimura T, Kume H, Homma Y.
    Impact of Gleason pattern 5 including tertiary pattern 5 on outcomes of salvage treatment for biochemical recurrence in pT2-3N0M0 prostate cancer.
    Int J Clin Oncol. 21(5):975-980, Oct, 2016.
  18. Makise N, Morikawa T, Nakagawa T, Ichimura T, Kawai T, Matsushita H, Kakimi K, Kume H, Homma Y, Fukayama M.
    MAGE-A expression, immune microenvironment, and prognosis in upper urinary tract carcinoma.
    Hum Pathol. 50:62-9, Apr, 2016.
  19. Matsushita H, Sato Y, Karasaki T, Nakagawa T, Kume H, Ogawa S, Homma Y, Kakimi K.
    Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma.
    Cancer Immunol Res. 4(5):463-71, May, 2016.
  20. Taguchi S, Kume H, Fukuhara H, Morikawa T, Kakutani S, Takeshima Y, Miyazaki H, Suzuki M, Fujimura T, Nakagawa T, Ishikawa A, Igawa Y, Homma Y.
    Symptoms at diagnosis as independent prognostic factors in retroperitoneal liposarcoma.
    Mol Clin Oncol. 4(2):255-260, Feb, 2016. Epub 2015 Dec 8.
  21. Yamada Y, Fujimura T, Fukuhara H, Miyagawa J, Miyazaki H, Nakagawa T, Kume H, Homma Y.
    Measuring Contact Pressure of Lower Extremities in Patients Undergoing Robot-Assisted Radical Prostatectomy.
    Urol Int.  96: 268-73, 2016.
  22. Fujimura T, Menon M, Fukuhara H, Kume H, Suzuki M, Yamada Y, Niimi A, Nakagawa T, Igawa Y, Homma Y.
    Validation of an educational program balancing surgeon training and surgical quality control during robot-assisted radical prostatectomy.
    Int J Urol. 23(2):160-6, Feb, 2016.
  23. Otsuka M, Taguchi S, Nakagawa T, Kawai T, Morikawa T, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Homma Y.
    Lower ureteral lesion is an independent predictor of intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
    Urol Oncol. 34(2):59.e9-13, Feb, 2016.
  24. Taguchi S, Akamatsu N, Nakagawa T, Gonoi W, Kanatani A, Miyazaki H, Fujimura T, Fukuhara H, Kume H, Homma Y.
    Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma.
    Clin Genitourin Cancer. 14(3):237-43, Jun, 2016.
  25. Sonpavde G, Pond GR, Choueiri TK, Mullane S, Niegisch G, Albers P, Necchi A, Di Lorenzo G, Buonerba C, Rozzi A, Matsumoto K, Lee JL, Kitamura H, Kume H, Bellmunt J.
    Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.
    Eur Urol. 69(4):634-41, Apr, 2016.
  26. Niimi A, Nomiya A, Yamada Y, Suzuki M, Fujimura T, Fukuhara H, Kume H, Igawa Y, Homma Y.
    Hydrodistension with or without fulguration of hunner lesions for interstitial cystitis: Long-term outcomes and prognostic predictors.
    Neurourol Urodyn. 35(8):965-969, Nov, 2016.
  27. Taguchi S, Nakagawa T, Uemura Y, Matsumoto A, Nagase Y, Kawai T, Tanaka Y, Yoshida K, Yamamoto S, Enomoto Y, Nose Y, Sato T, Ishikawa A, Fujimura T, Fukuhara H, Kume H, Homma Y.
    Validation of major prognostic models for metastatic urothelial carcinoma using a multi-institutional cohort of the real world.
    World J Urol. 34(2):163-71, Feb, 2016.

原著論文-和文

口頭・ポスター発表-国際学会・研究会

口頭・ポスター発表-国内学会・研究会

著書・総説

その他